Metabolic acidosis: an unrecognized cause of morbidity in the patient with chronic kidney disease.
about
Nitric oxide originating from NOS1 controls oxygen utilization and electrolyte transport efficiency in the diabetic kidney.Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockadeHigh serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients.Association of serum bicarbonate with incident functional limitation in older adultsRenal oxidative stress, oxygenation, and hypertensionMolecular mechanisms of acid-base sensing by the kidneyIntrarenal oxygen in diabetes and a possible link to diabetic nephropathy.Intrarenal oxygen and hypertension.Timing of onset of CKD-related metabolic complicationsSerum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study.Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.Renal tubulointerstitial hypoxia: cause and consequence of kidney dysfunction.The renal microcirculation in sepsis.Iodinated contrast media inhibit oxygen consumption in freshly isolated proximal tubular cells from elderly humans and diabetic rats: Influence of nitric oxide.Renal tissue oxygenation in essential hypertension and chronic kidney diseaseHypoxia-inducible factor-1α (HIF-1α) protein diminishes sodium glucose transport 1 (SGLT1) and SGLT2 protein expression in renal epithelial tubular cells (LLC-PK1) under hypoxiaRenal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes.Interleukin 6 increases dysfunction of organs in sepsis rats through sirtuin 1.Kidney oxygen consumption, carbonic anhydrase, and proton secretion.Nitric oxide inhibition and the impact on renal nerve-mediated antinatriuresis and antidiuresis in the anaesthetized rat.Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis.Urine Ammonium, Metabolic Acidosis and Progression of Chronic Kidney Disease
P2860
Q33655702-0C0A982F-3174-489E-92A1-15A49EFC1661Q34426346-7D97FD39-79B2-4031-A169-C5F1332887E1Q34539337-A6CFF59A-87B5-4B1C-90FD-1C603675FDD3Q34629786-39291CA3-5E5A-4198-B7B0-A397E461CF03Q35543371-D6BBBD44-B95C-4FC8-AC27-DC2D4457DD73Q35917532-9AFF9224-F141-47D5-B242-41AE8BDA3C47Q36604424-24950F3D-5BE1-430A-AB88-B6DFDF14B943Q36604426-8D5C4A25-991D-4513-A6AA-6C983E5517C6Q37042178-77E24397-D5D8-45F7-8B0E-513EA0EAA0E5Q37075325-65D1F360-7CCD-428D-8867-DAB59B6D80A0Q37142481-912A804A-89A4-4167-BE06-09AB7E42EA2CQ37872367-73694E30-DA0B-4E49-A6C5-EE3E6B750BEEQ38213464-DD9A084C-EAAB-4A89-9001-CAA63571113EQ39641624-823CF888-3188-445F-9E7F-6E2DE6470ACDQ41498684-806B7AA4-C9DA-4CEC-8490-48491B788B73Q41848385-DFC1F953-3704-45C5-BA70-A36C7C32F7EDQ42521594-6B5A5828-6992-4B74-BC8D-BD146BEA78AEQ42965142-E2AB6A4F-A4F0-41EA-BE9D-33C667F1B87CQ46149916-280DABA1-FF34-4A79-B286-4E4221E996DAQ46765852-D2FADDC6-E86F-47B2-9DCD-4C4CAE9A62FBQ52682131-FA723E33-CEEE-427D-A952-6E1D6388E5BCQ56394703-D9AC8FF8-D827-4C36-8B9D-E17D671A36F4
P2860
Metabolic acidosis: an unrecognized cause of morbidity in the patient with chronic kidney disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Metabolic acidosis: an unrecog ...... t with chronic kidney disease.
@ast
Metabolic acidosis: an unrecog ...... t with chronic kidney disease.
@en
type
label
Metabolic acidosis: an unrecog ...... t with chronic kidney disease.
@ast
Metabolic acidosis: an unrecog ...... t with chronic kidney disease.
@en
prefLabel
Metabolic acidosis: an unrecog ...... t with chronic kidney disease.
@ast
Metabolic acidosis: an unrecog ...... t with chronic kidney disease.
@en
P1476
Metabolic acidosis: an unrecog ...... t with chronic kidney disease.
@en
P2093
James L Bailey
P304
P356
10.1111/J.1523-1755.2005.00450.X
P577
2005-07-01T00:00:00Z